Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC) treated in routine practice is limited. The aim of this retrospective study is to present data on treatment patterns and survival in an unselected patient population with ED SCLC. Methods: All patients diagnosed with ED SCLC between 2008 and 2014 in six Dutch large teaching hospitals (Santeon network) were included. We collected data on patient characteristics, systemic treatments, overall survival (OS), dose reductions (<80% of initial dose) and early discontinuation (<4 cycles). Results: From 792 diagnosed patients, 568 (72%) started with first-line treatment. Of these patients, 41% received second-line treatment. Only 68 patients received...
OBJECTIVE: The aim of the study is to analyse long-term results of patients with small cell lung can...
In this observational study, we assessed treatment patterns and prognostic factors in patients with ...
Objectives: Recent treatment patterns for small cell lung cancer (SCLC) in the Netherlands were unkn...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Purpose: The aim of this study is to assess how clinical outcomes in real-world (effectiveness) corr...
International audienceBackground: Small cell lung cancer (SCLC) is a highly aggressive entity of lun...
Purpose The aim of this study is to assess how clinical outcomes in real-world (effectiveness) corre...
BackgroundImmune checkpoint inhibitors (ICIs) have changed the therapeutic options for extensive-sta...
The prognosis for extensive-stage small cell lung cancer (ES-SCLC) is poor. Real-world evidence can ...
OBJECTIVE: The aim of the study is to analyse long-term results of patients with small cell lung can...
In this observational study, we assessed treatment patterns and prognostic factors in patients with ...
Objectives: Recent treatment patterns for small cell lung cancer (SCLC) in the Netherlands were unkn...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Objective: Clinical outcome data on patients with extensive disease small cell lung cancer (ED SCLC)...
Purpose: The aim of this study is to assess how clinical outcomes in real-world (effectiveness) corr...
International audienceBackground: Small cell lung cancer (SCLC) is a highly aggressive entity of lun...
Purpose The aim of this study is to assess how clinical outcomes in real-world (effectiveness) corre...
BackgroundImmune checkpoint inhibitors (ICIs) have changed the therapeutic options for extensive-sta...
The prognosis for extensive-stage small cell lung cancer (ES-SCLC) is poor. Real-world evidence can ...
OBJECTIVE: The aim of the study is to analyse long-term results of patients with small cell lung can...
In this observational study, we assessed treatment patterns and prognostic factors in patients with ...
Objectives: Recent treatment patterns for small cell lung cancer (SCLC) in the Netherlands were unkn...